Second-line chemotherapy for ovarian cancer.
D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008722:Methods; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011372:Progestins / Q000627:therapeutic use
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D011372:Progestins